AAN 2025: Long-term outcome data on steroid regimens in MG may guide treatment standards
The research presented by Yangyu Huang and colleagues was a cohort study based on a single-centre prospective MG registry.
Comment & Opinion
AD/PD 2025: Reporting of first real-world data for Leqembi focuses on operational challenges and safety
AD/PD 2025: First real-world data report for Leqembi focuses on operational challenges
Uveitis market expected to reach $1.5bn across 7MM by 2033
IO360 Summit: Improving CAR-T cell therapy manufacture and accessibility
AD/PD 2025: DHTs can detect disease progression in patients with early Parkinson’s
IO360 summit: CAR-T cell therapy applications beyond blood cancer
Weight loss implants to increase compliance and cut admin burden for patients
